|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2002-4-30
|
|
pubmed:abstractText |
PV701, a replication-competent strain of Newcastle disease virus, causes regression of tumor xenografts after intravenous administration. This phase I study was designed to define the maximum-tolerated dose (MTD) and safety of single and multiple intravenous doses of PV701 as a single agent in patients with cancer.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BamatMichael KMK,
pubmed-author:CohenGary IGI,
pubmed-author:GoldbergStuartS,
pubmed-author:GroeneWilliam SWS,
pubmed-author:GrossPeterP,
pubmed-author:LorenceRobert MRM,
pubmed-author:MarshallJohn LJL,
pubmed-author:MeropolNeal JNJ,
pubmed-author:O'NeilJames DJD,
pubmed-author:PecoraAndrew LAL,
pubmed-author:RabinHarveyH,
pubmed-author:RizviNaiyerN,
pubmed-author:RobertsM ScotMS,
pubmed-author:StermanDanielD
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2251-66
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11980996-Adult,
pubmed-meshheading:11980996-Aged,
pubmed-meshheading:11980996-Aged, 80 and over,
pubmed-meshheading:11980996-Female,
pubmed-meshheading:11980996-Gene Therapy,
pubmed-meshheading:11980996-Humans,
pubmed-meshheading:11980996-Infusions, Intravenous,
pubmed-meshheading:11980996-Male,
pubmed-meshheading:11980996-Middle Aged,
pubmed-meshheading:11980996-Neoplasms,
pubmed-meshheading:11980996-Newcastle disease virus,
pubmed-meshheading:11980996-Treatment Outcome,
pubmed-meshheading:11980996-Virus Replication
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers.
|
|
pubmed:affiliation |
Cancer Center at Hackensack University Medical Center, Hackensack, NJ 07601, USA. apecora@humed.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
